Related Experiment Videos
Acute stroke: pathophysiology, diagnosis, and treatment
1School of Nursing, La Salle University, Philadelphia, Pennsylvania 19141, USA. Frizzell@Lasalle.edu
AACN Clinical Issues
|November 5, 2005
Summary
Stroke, a leading cause of death, involves altered cerebral circulation. Early diagnosis and treatments like thrombolytic therapy are crucial for managing ischemic, embolic, and hemorrhagic stroke events.
Area of Science:
- Neurology
- Cardiovascular Science
- Public Health
Background:
- Stroke is the third leading cause of death in the U.S., characterized by altered cerebral circulation.
- Key risk factors include hypertension, family history, and diabetes mellitus.
- Stroke subtypes include ischemic, embolic, and hemorrhagic events, each with distinct pathophysiological mechanisms.
Purpose of the Study:
- To provide an overview of stroke, including its risk factors, subtypes, and diagnostic methods.
- To discuss current treatment strategies, emphasizing thrombolytic therapy for specific stroke types.
- To highlight recommendations for future stroke care and research directions.
Main Methods:
- Review of existing literature on stroke etiology, risk factors, and classification.
- Description of diagnostic tools such as computed tomography (CT) scans, magnetic resonance imaging (MRI), and the National Institutes of Health Stroke Scale (NIHSS).
- Summary of current therapeutic interventions, focusing on thrombolytic agents for ischemic and embolic strokes.
Main Results:
- Ischemic and embolic strokes result from thrombi and emboli due to atherosclerosis, leading to neuronal injury.
- Intracerebral hemorrhage stems from cerebral vessel rupture, often linked to hypertension.
- Diagnosis relies on imaging (CT, MRI) and clinical scales (NIHSS), with treatment tailored to stroke etiology.
Conclusions:
- Thrombolytic therapy is a primary treatment for thrombotic and embolic strokes.
- Future stroke care recommendations emphasize the establishment of specialized stroke centers.
- Ongoing research should explore neuroprotective therapies to improve stroke outcomes.